GALIMBERTI et al. V. ASANUMA et al. - Page 16




          Interference No. 103,303                                                    


          copolymers.  These are the only arguments by the party                      
          Galimberti et al. to predicate the separate patentability of                
          its claims.  These arguments are addressed seriatim below.                  
                                          I                                           
               With respect to the homogeneous argument, we note that                 
          homogeneous is not a limitation recited in the party                        
          Galimberti et al.'s claim 1.  It is settled that a claim is to              
          be given its broadest reasonable interpretation and that a                  
          limitation from specification is not to be read into the                    
          claim.  In re Van Geuns, 988 F.2d 1181, 1184, 26 USPQ2d 1057,               
          1059 (Fed. Cir. 1993); Intervet America, Inc. v. Kee-Vet Lab.               
          Inc., 887 F.2d 1050, 1053, 12 USPQ2d 1474, 1476 (Fed. Cir.                  
          1989).  The reason for the rule is simply that during patent                
          prosecution when claims can be amended, ambiguities should be               
          recognized, scope and breadth of language explored, and                     
          clarification imposed. In re Zletz, 893 F.2d 319, 321-22, 13                
          USPQ2d 1320, 1322 (Fed. Cir. 1989).  The foregoing rule of                  
          claim construction applies to patent claims which correspond                
          to the count.  Lamont v. Berguer, 7 USPQ2d 1580, 1582 (Bd.                  
          Pat. App. & Int. 1988).  Since Galimberti et al.'s claim 1                  
          does not recite that the copolymer is homogeneous, we will not              
          read the limitation into the claim.                                         

                                        -16-                                          



Page:  Previous  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  Next 

Last modified: November 3, 2007